Sign In
Not register? Register Now!
Essay Available:
Pages:
3 pages/β‰ˆ825 words
Sources:
No Sources
Style:
APA
Subject:
Accounting, Finance, SPSS
Type:
Essay
Language:
English (U.S.)
Document:
MS Word
Date:
Total cost:
$ 14.04
Topic:

Iovance Biotherapeutics Company Analysis Accounting, Finance Essay

Essay Instructions:

I have finished the first action. You need to help me to finish the next two sections. The company should analysis is Iovance Biotherapeutics.
SECTION 2 - Significant Issues. A discussion of Current or Pending issues facing the Company (representing 25 points of the assignment’s total grade). The issues may be positive or negative BUT DO NOT address whether they are positive or negative in this section; (that determination is left to your discretion on section 3 of the assignment).
You must identify and discuss at least three issues. At least one of these issues should be one you personally developed/identified/detected as a result of your research. The issue you personally identify/develop/detect should NOT be one that has been documented in some media publication or news article AND you must identify if as the issue you developed. You must identify the issue you personally identified or developed. Your self-developed issue is a clear indication that you meet the minimum requirements of the introduction of critical thinking program outcomes.
This section must be at least 1β…” pages in length.
There must be a separate paragraph for each of the 3 issues you identify.
Each issue must be adequately explained and justified as a valid issue. In other words, make your case on why it is an issue or what makes it an issue.
Each issue must be supported with at least 3 supporting points.
SECTION 3 – Opinion Section (representing 30 points of the assignment’s total grade) Take a position on the issues you identified based on observations you have made from your research. In other words, specify whether the issue is favorable or unfavorable for the company. After you have taken a position on each of the three issues and supported each of them with three talking points, conclude your paper with an opinion paragraph as to whether you would or would not invest in this company and explain why in that paragraph.
Your opinions must refer to or be related to the items noted in the previous two sections.
You must take a position on the three issues you identified in section 2 and identify the position as favorable or unfavorable toward the company.
You must support your position in a separate paragraph for each of the 3 issues.
You must provide 3 talking points to support your position on favorability (favorable or unfavorable).
In your conclusion state whether you would or would not invest in this company and why.
This section must be at least 1β…” pages in length.
Then I will upload an example of the essay and the finished part. And I also need a Work Cited.

Essay Sample Content Preview:

Iovance Biotherapeutics
Dingkai Chen
2018/9/21
Managerial Accounting
Company Overview
Iovance Biotherapeutics, Inc. (IOVA.US) was founded in 2007, it was formerly known as Lion Biotechnologies, Inc. Its headquarters is in New York City. Now the president and CEO of the Iovance Biotherapeutics is Maria Fardis, its CFO is Timothy E Morris, and the General Counsel is Dr. Frederick G. Vogt. Currently, the company is in collaboration with MD Anderson and Moffitt Cancer Centre to boost the efficiency of LN-145. LN-145 is a drug the company believes can cure lung cancer through immunotherapy.
Therefore, Iovance Biotherapeutics is a biopharmaceutical company focused on cancer immunotherapy through the power of the patient's immune system to eliminate cancer cells, (Rohaan, 2018). In addition, Iovance Biotherapeutics also pays attention to its products’ development and commercialization. As a result, Iovance Biotherapeutics is focused on the development and commercialization of novel cancer immunotherapy based on tumor infiltrating lymphocytes (TIL). This approach, also known as adoptive T-cell therapy, was initially developed by Dr. Steven A. Rosenberg at the National Cancer Institute (NCI). Therefore, during Phase 2 clinical trials conducted at the NCI, 56% and 24% of patients were treated with this technology.
However, the net loss for the quarter ended March 31, 2018 was $26.5 million, or $0.31 per share, while the net loss for the same period ended March 31, 2017 was $20.7 million, or $0.33 per share. More so, general and administrative expenses for the quarter ended March 31, 2018 were $7 million, an increase of $1.7 million from $5.3 million for the same period ended March 31, 2017.
The main reason for the increase was due to the increase in wage-related costs by $900,000. Consequently, Personnel, professional services, and legal fees increased by $600,000. This was initiated by the need to support the expansion of the company's intellectual property portfolio. On the other hand, the company held cash and cash equivalents of $297.1 million at March 31, 2018, compared to $145.4 million on December 31, 2017. However, the company expects the year-end balance of cash, cash equivalents, and short-term investments to be between $190.210 million.
Significant company Issues
The United States of America is among nations in the world with industrious and competitive markets. Considering such markets, it is safe to say that the revenue of Iovance Biotherapeutics portray the strong commercialization aspect of the company. Interestingly, the company has only been in operation for a few years compared to other companies in the biotherapeutics field. Furthermore, the company’s forecast of year-end cash and cash equivalents of $190 to 210 million shows its desire to constantly increase its cash in hand to cater for routine expenses.
However, the company’s revenue suffered relatively due to increase in general expenses. Generally, Cancer treatment is always expensive. Therefore, only qualified and competent professionals are required to work on such programs. This may explain the reason why wage related costs increased. More so, legal and professional expenses took a huge cut from the revenues. Neverthel...
Updated on
Get the Whole Paper!
Not exactly what you need?
Do you need a custom essay? Order right now:
Order

πŸ‘€ Other Visitors are Viewing These APA Essay Samples:

HIRE A WRITER FROM $11.95 / PAGE
ORDER WITH 15% DISCOUNT!
Order Now